Wescott Financial Advisory Group LLC Sells 2,960 Shares of CVS Health Corporation $CVS

Wescott Financial Advisory Group LLC lowered its position in shares of CVS Health Corporation (NYSE:CVS) by 41.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,152 shares of the pharmacy operator’s stock after selling 2,960 shares during the period. Wescott Financial Advisory Group LLC’s holdings in CVS Health were worth $281,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in CVS. McIlrath & Eck LLC increased its stake in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 174 shares during the period. Costello Asset Management INC increased its stake in CVS Health by 281.3% during the 1st quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 422 shares during the period. Stone House Investment Management LLC bought a new position in CVS Health during the 1st quarter worth $39,000. Park Square Financial Group LLC bought a new position in CVS Health during the 4th quarter worth $43,000. Finally, GW&K Investment Management LLC increased its stake in CVS Health by 39.4% during the 1st quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator’s stock worth $43,000 after acquiring an additional 180 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on CVS. Robert W. Baird upgraded CVS Health from a “neutral” rating to an “outperform” rating and raised their price objective for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Morgan Stanley raised their target price on CVS Health from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Truist Financial raised their target price on CVS Health from $82.00 to $84.00 and gave the company a “buy” rating in a report on Monday, May 12th. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Finally, Bernstein Bank reduced their target price on CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a report on Wednesday, July 16th. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $76.67.

CVS Health Trading Up 0.8%

NYSE CVS opened at $71.4010 on Friday. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $72.51. The company has a market cap of $90.56 billion, a price-to-earnings ratio of 19.94, a price-to-earnings-growth ratio of 0.78 and a beta of 0.58. The business’s fifty day moving average is $65.43 and its 200 day moving average is $65.01.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter last year, the business posted $1.83 EPS. CVS Health’s revenue for the quarter was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.7%. The ex-dividend date of this dividend was Tuesday, July 22nd. CVS Health’s dividend payout ratio (DPR) is currently 74.30%.

Insider Transactions at CVS Health

In related news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction that occurred on Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director directly owned 12,007 shares in the company, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.